Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
Sales | 5,789,000 | 6,130,000 | 5,743,000 | 5,799,000 | 5,265,000 |
Cost of Goods | 1,245,000 | 1,313,000 | 1,460,000 | 1,526,000 | 1,259,000 |
Gross Profit | 4,544,000 | 4,819,000 | 4,283,000 | 4,273,000 | 4,006,000 |
Operating Expenses | 2,888,000 | 3,143,000 | 2,872,000 | 2,723,000 | 2,806,000 |
Operating Income | 1,656,000 | 1,674,000 | 1,411,000 | 1,550,000 | 1,200,000 |
Interest Expense | 120,000 | 166,000 | 0 | 0 | 0 |
Other Income | 207,000 | 241,000 | 75,000 | -205,000 | 293,000 |
Pre-tax Income | 1,743,000 | 1,749,000 | 1,486,000 | 1,345,000 | 1,493,000 |
Income Tax | 513,000 | 525,000 | 443,000 | 370,000 | 278,000 |
Net Income Continuous | 1,230,000 | 1,220,000 | 1,043,000 | 968,000 | 1,211,000 |
Net Income | $1,230,000 | $1,220,000 | $1,043,000 | $968,000 | $1,211,000 |
EPS Basic Total Ops | 0.38 | 0.38 | 0.32 | 0.30 | 0.36 |
EPS Basic Continuous Ops | 0.38 | 0.38 | 0.32 | 0.30 | 0.36 |
EPS Diluted Total Ops | 0.38 | 0.38 | 0.32 | 0.30 | 0.36 |
EPS Diluted Continuous Ops | 0.38 | 0.38 | 0.32 | 0.30 | 0.36 |
EBITDA(a) | $1,959,000 | $1,995,000 | $1,720,000 | $1,903,000 | $2,115,000 |